The reimbursement of new anti-obesity treatments was formalized on Thursday only for some patients with the most severe obesity. These drugs, among the most sold in the pharmaceutical industry, have profoundly transformed the care of millions of patients in the world. How do they work? - Anti-obesity medicines: Wegovy, Mounjaro, Ozempic... how do they work? (Health and well-being).
The reimbursement of new anti-obesity treatments was formalized on Thursday only for some patients with the most severe obesity. These drugs, among the most sold in the pharmaceutical industry, have profoundly transformed the care of millions of patients in the world. How do they work? - Anti-obesity medicines: Wegovy, Mounjaro, Ozempic... how do they work? (Health and well-being).
On Thursday, 28 May, France became the first European country to repay the anti-obesity medicines Wegovy and Mounjaro. A decision that highlights the extent of a growing scourge in the country: almost half of French adults are overweight and 10 million people are affected by obesity.